Gilead Sciences is commercializing medicines in Europe, with Anu Osinusi as VP of Clinical Development and Cynthia Levy supporting IDEAL results for Livdelzi.
2 reports, 2 independent
Updated Oct 23
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Gilead Sciences is commercializing medicines in Europe, with Anu Osinusi as VP of Clinical Development and Cynthia Levy supporting IDEAL results for Livdelzi.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Gilead reports revenue changes and expands HIV prevention drug collaboration.1 source
Gilead commercializes Livdelzi in Europe; key personnel Anu Osinusi and Cynthia Levy involved.1 source
Keep exploring
The entities involved
-
Gilead Sciences
American company
-
Europe
terrestrial continent located in north-western Eurasia